| RNA‐PROTACs: degraders of RNA‐binding proteins A Ghidini, A Cléry, F Halloy, FHT Allain, J Hall Angewandte Chemie 133 (6), 3200-3206, 2021 | 119 | 2021 |
| Recessive mutations in RTN4IP1 cause isolated and syndromic optic neuropathies C Angebault, PO Guichet, Y Talmat-Amar, M Charif, S Gerber, ... The American Journal of Human Genetics 97 (5), 754-760, 2015 | 62 | 2015 |
| Synthesis and cellular activity of stereochemically-pure 2′-O-(2-methoxyethyl)-phosphorothioate oligonucleotides M Li, HL Lightfoot, F Halloy, AL Malinowska, C Berk, A Behera, ... Chemical communications 53 (3), 541-544, 2017 | 51 | 2017 |
| WFS1 in optic neuropathies: mutation findings in nonsyndromic optic atrophy and assessment of clinical severity J Grenier, I Meunier, V Daien, C Baudoin, F Halloy, B Bocquet, C Blanchet, ... Ophthalmology 123 (9), 1989-1998, 2016 | 49 | 2016 |
| Innovative developments and emerging technologies in RNA therapeutics F Halloy, A Biscans, KE Bujold, A Debacker, AC Hill, A Lacroix, O Luige, ... RNA Biology 19 (1), 313-332, 2022 | 25 | 2022 |
| Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria J Barman-Aksözen, F Halloy, PS Iyer, D Schümperli, AE Minder, J Hall, ... Molecular genetics and metabolism 128 (3), 304-308, 2019 | 20 | 2019 |
| Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria F Halloy, PS Iyer, P Ćwiek, A Ghidini, J Barman-Aksözen, ... Nucleic Acids Research 48 (9), 4658-4671, 2020 | 17 | 2020 |
| Chemical synthesis of long RNAs with terminal 5′‐phosphate groups U Pradère, F Halloy, J Hall Chemistry–A European Journal 23 (22), 5210-5213, 2017 | 16 | 2017 |
| Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria F Halloy, PS Iyer, A Ghidini, V Lysenko, J Barman-Aksözen, ... Cell Chemical Biology 28 (8), 1221-1234. e6, 2021 | 11 | 2021 |
| Carrier-free gene silencing by amphiphilic nucleic acid conjugates in differentiated intestinal cells E Moroz, SH Lee, K Yamada, F Halloy, S Martínez-Montero, H Jahns, ... Molecular Therapy-Nucleic Acids 5, 2016 | 11 | 2016 |
| Increased Affinity of 2′‐O‐(2‐Methoxyethyl)‐Modified Oligonucleotides to RNA through Conjugation of Spermine at Cytidines E Decuypere, A Lepikhina, F Halloy, J Hall Helvetica Chimica Acta 102 (12), e1900222, 2019 | 5 | 2019 |
| Efficient Synthesis of 2'-O-Methoxyethyl Oligonucleotide-Cationic Peptide Conjugates F Halloy, AC Hill, J Hall ChemMedChem 16 (22), 3391-3395, 2021 | 4 | 2021 |
| Peptide Conjugates of a 2′-O-Methoxyethyl Phosphorothioate Splice-Switching Oligonucleotide Show Increased Entrapment in Endosomes AC Hill, JP Becker, D Slominski, F Halloy, C Søndergaard, J Ravn, J Hall ACS omega 8 (43), 40463-40481, 2023 | 1 | 2023 |
| Systemic delivery of a splice-switching oligonucleotide heteroduplex corrects splicing in central nervous system and muscle in spinal muscular atrophy mice F Halloy, N Ahlskog, M Wood bioRxiv, 2024.01. 24.577012, 2024 | | 2024 |
| Analysis of Oligonucleotide Biodistribution and Metabolization in Experimental Animals (in Alternative splicing pp335-350) J Hall, D Schümperli, F Halloy Methods in Molecular Biology 2537, 2022 | | 2022 |
| Analysis of Oligonucleotide Biodistribution and Metabolization in Experimental Animals F Halloy, P Brönnimann, J Hall, D Schümperli Alternative Splicing: Methods and Protocols, 335-350, 2022 | | 2022 |
| Therapeutic Strategies for the Treatment of Erythropoietic Protoporphyria F Halloy ETH Zurich, 2020 | | 2020 |
| Genetic analyses of autosomal optic neuropathies reveal novel physiopathological pathways involved in optic nerve degeneration G Lenaers, F Halloy, N Hieu, C Megy, C Delettre, I Meunier, A Roubertie, ... Acta Ophthalmologica 91, 2013 | | 2013 |
| New candidate genes for inherited optic atrophy C Delettre, M Hebrard, F Halloy, C Hamel, G Lenaers Investigative Ophthalmology & Visual Science 54 (15), 1356-1356, 2013 | | 2013 |
Alice GhidiniTeam Lead Structure&Characterization RNA therapeuticsVerified email at sixfold.bio
